Leafy Tunnel
Overview
Leafy Tunnel is a venture capital firm that invests in companies operating in the alternative medicine sectors, with a focus on medical cannabis and psychedelics.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Emerald | Oct 2026 | Grant | Co-investor |
| Naiture | Dec 2021 | Angel | Co-investor |
| NAITUR.AI | Dec 2021 | Seed | Lead |
| 2A Biosciences | Mar 2023 | Seed | Co-investor |
| Ceretype Neuromedicine, Inc. | Jan 2024 | Seed | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Leafy Tunnel based?
Leafy Tunnel is headquartered in London, United Kingdom.
When was Leafy Tunnel founded?
Leafy Tunnel was founded in 2020.
How many portfolio companies does Leafy Tunnel have?
Leafy Tunnel has 8 portfolio companies in Caplight's dataset.
What are some companies in Leafy Tunnel's portfolio?
Portfolio companies visible on Caplight include Emerald, Naiture, NAITUR.AI, 2A Biosciences, Ceretype Neuromedicine, Inc..
What was Leafy Tunnel's most recent investment shown here?
Leafy Tunnel's most recent investment in this portfolio sample was in Emerald in 2026.
What sectors does Leafy Tunnel focus on?
Leafy Tunnel focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Enterprise Software, Media, Entertainment & Gaming, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure.
What company stages does Leafy Tunnel focus on?
Leafy Tunnel typically invests at the Early stage.
What is Leafy Tunnel's AUM?
Leafy Tunnel's assets under management are estimated between $30.0M and $30.0M.